ALKS 5461

ALKS-5461 · Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for ALKS 5461, covering 2011-08-23 to 2021-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) [Phase 3]